Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01488552
Title Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pancreatic Cancer Research Team
Indications

pancreatic adenocarcinoma

Therapies

Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin

Gemcitabine + Nab-paclitaxel

Metformin

Age Groups: adult
Covered Countries USA


No variant requirements are available.